Beyond Medical Technologies Inc (TSE:DOCT)
:DOCT
Top Page
Beyond Medical Technologies Inc
(DOCT)
Select Model
Select Model
Rating:42Neutral
Price Target:
C$0.21
▼(-12.08% Downside)
Action:ReiteratedDate:01/14/26
The score is held down primarily by weak financial performance—ongoing losses, negative cash flow, and missing revenue since 2022—plus added financing risk from the TTM debt increase. Technicals are also negative with the price below major moving averages and a negative MACD, while valuation offers little support given the loss-driven negative P/E and no dividend.
Positive Factors
Balance sheet recovery
The restoration of positive equity in the TTM period signals improved solvency and a larger asset base. That durable improvement increases the firm's ability to raise capital, negotiate with creditors and suppliers, and provides a steadier financial foundation to pursue operational recovery over the medium term.
Negative Factors
No reported revenue since 2022
A multi-year absence of revenue eliminates visibility into demand and product-market fit, preventing organic cash generation. Without durable revenue, the business model remains unproven, forcing reliance on financing and raising the risk of dilution, restructuring, or failure unless revenues recur.
Read all positive and negative factors
Positive Factors
Negative Factors
Balance sheet recovery
The restoration of positive equity in the TTM period signals improved solvency and a larger asset base. That durable improvement increases the firm's ability to raise capital, negotiate with creditors and suppliers, and provides a steadier financial foundation to pursue operational recovery over the medium term.
Read all positive factors
Beyond Medical Technologies Inc (DOCT) vs. iShares MSCI Canada ETF (EWC)
Market Cap
C$6.23M
Dividend YieldN/A
Average Volume (3M)29.78K
Price to Earnings (P/E)28.3
Beta (1Y)1.46
Revenue GrowthN/A
EPS Growth-55.56%
CountryCA
EmployeesN/A
SectorIndustrials
Sector Strength72
IndustryIndustrial - Pollution & Treatment Controls
Share Statistics
EPS (TTM)<0.01
Shares Outstanding32,793,960
10 Day Avg. Volume26,926
30 Day Avg. Volume29,782
Financial Highlights & Ratios
PEG Ratio20.13
Price to Book (P/B)-0.45
Price to Sales (P/S)0.00
P/FCF Ratio-2.52
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Beyond Medical Technologies Inc Business Overview & Revenue Model
Company Description
Republic Technologies, Inc. engages in the manufacturing of personal protective equipment. It operates through the following segments: Corporate, PPE Sector, and Waste Treatment. The company was founded by Bharath Bhushan on November 29, 2006 and ...
How the Company Makes Money
Beyond Medical Technologies Inc generates revenue through the sale of its proprietary medical devices and technology solutions to healthcare providers, hospitals, and clinics. The company also monetizes its telemedicine platforms through subscript...
Beyond Medical Technologies Inc Financial Statement Overview
Summary
Income Statement
8
Very Negative
Balance Sheet
22
Negative
Cash Flow
14
Very Negative
| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 943.42K | 208.66K |
| Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 | -250.00K | -73.24K |
| EBITDA | -1.46M | -365.88K | -37.96K | -773.00K | -1.34M | -6.35M |
| Net Income | -1.73M | -285.00 | -596.00K | -1.40M | -2.91M | -6.52M |
Balance Sheet | ||||||
| Total Assets | 7.14M | 13.80K | 95.64K | 608.18K | 1.95M | 1.84M |
| Cash, Cash Equivalents and Short-Term Investments | 7.06M | 13.22K | 64.14K | 536.75K | 1.43M | 624.21K |
| Total Debt | 1.27M | 60.00K | 30.00K | 0.00 | 85.09K | 165.01K |
| Total Liabilities | 5.26M | 634.46K | 430.35K | 346.94K | 413.28K | 361.85K |
| Stockholders Equity | 1.88M | -620.66K | -334.72K | 261.25K | 1.54M | 1.48M |
Cash Flow | ||||||
| Free Cash Flow | -470.33K | -109.77K | -527.04K | -894.01K | -1.47M | -2.07M |
| Operating Cash Flow | -470.33K | -109.77K | -527.04K | -894.01K | -1.40M | -1.83M |
| Investing Cash Flow | -2.97M | 0.00 | 0.00 | 0.00 | -467.99K | -260.27K |
| Financing Cash Flow | 5.53M | 30.00K | 30.00K | 0.00 | 2.67M | -65.96K |
Beyond Medical Technologies Inc Technical Analysis
Negative
0.24
Price Trends
0.20
Negative
0.24
Negative
0.42
Negative
Market Momentum
>-0.01
Negative
51.74
Neutral
100.00
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:DOCT, the sentiment is Negative. The current price of 0.24 is above the 20-day moving average (MA) of 0.18, above the 50-day MA of 0.20, and below the 200-day MA of 0.42, indicating a neutral trend. The MACD of >-0.01 indicates Negative momentum. The RSI at 51.74 is Neutral, neither overbought nor oversold. The STOCH value of 100.00 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for TSE:DOCT.
Beyond Medical Technologies Inc Peers Comparison
UnderperformOutperform
Sector (63)
TSE:DOCT
Beyond Medical Technologies Inc
0.19
0.05
35.71%
TSE:APL
Appulse
0.30
0.10
53.85%
TSE:ATMO
Atmofizer Technologies Inc. Class B
0.06
0.00
0.00%
Beyond Medical Technologies Inc Corporate Events
Business Operations and StrategyDelistings and Listing ChangesPrivate Placements and Financing
Republic Technologies Expands ETH Holdings and Infrastructure
Positive
Dec 11, 2025
Republic Technologies Inc. has significantly expanded its ETH holdings, now totaling 1,570.60 ETH, and has seen a 23% appreciation in value. This expansion is part of their strategy to strengthen their infrastructure and enhance their capacity for...
Private Placements and Financing
Republic Technologies Secures Initial US$10 Million from Convertible Note Facility
Positive
Dec 8, 2025
Republic Technologies Inc. has successfully completed the first drawdown of its US$100 million secured convertible note facility, raising US$10 million. The funds will primarily be used to acquire Ethereum to support the company’s validator ...
Business Operations and StrategyDelistings and Listing Changes
Republic Technologies Expands U.S. Market Presence with OTCQB Listing
Positive
Dec 4, 2025
Republic Technologies Inc. has announced its listing on the OTCQB Venture Market in the United States under the ticker symbol DOCKF, with its shares now eligible for electronic clearing through the Depository Trust Company. This move is part of th...
Business Operations and StrategyPrivate Placements and Financing
Republic Technologies Secures $100M Convertible Note Facility to Boost Ethereum Infrastructure
Positive
Nov 21, 2025
Republic Technologies Inc. has entered into a definitive investment agreement for a secured convertible note facility worth up to US$100 million with an institutional investor. The financing will support the company’s blockchain-based attest...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.